|
|
Article: Dr. Raymond Johnson Presents Preliminary Outcomes Data on PROMETA(TM) Treated Patients at Florida Society of Addiction Medicine (FSAM) Conference.
- Article from:
- Business Wire
- Article date:
- March 27, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LOS ANGELES -- 92% of Patients Given PROMETA and Intensive Outpatient Therapy Entered Remission from Alcohol and Stimulant Dependencies
Hythiam, Inc. (Nasdaq:HYTM), which licenses the PROMETA(TM) treatment protocols designed to target the biology of substance dependence, announced today that Dr. Raymond Johnson reported his preliminary findings in clinical experience with 52 private pay patients, who were treated with PROMETA for alcohol and stimulant dependence, in a special session of the Florida Society of Addiction Medicine's (FSAM) Annual Conference on Addictions on March 24th. The presentation discussed results for 24 patients who were treated for alcohol ...